title: Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1.
authors: Corinne
authors: C
authors: De Laet
authors: Vanessa Terrones
authors: VT
authors: Munoz
authors: Jaak
authors: J
authors: Jaeken
authors: Baudouin
authors: B
authors: François
authors: Dietbrandt
authors: D
authors: Carton
authors: Etienne M
authors: EM
authors: Sokal
authors: Bernard
authors: B
authors: Dan
authors: Philippe J
authors: PJ
authors: Goyens
mesh_terms: D000293:Adolescent; D001530:Belgium; D002648:Child; D002675:Child, Preschool; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D003512:Cyclohexanones / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D007361:Intelligence Tests; D008297:Male; D009483:Neuropsychological Tests; D009579:Nitrobenzoates / Q000627:therapeutic use*; D010649:Phenylalanine / Q000097:blood; D016896:Treatment Outcome; D014443:Tyrosine / Q000097:blood; D020176:Tyrosinemias / Q000150:complications / Q000188:drug therapy*
chemical_list: D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D009579:Nitrobenzoates; D014443:Tyrosine; D010649:Phenylalanine; C077073:nitisinone